ScreenerHero

JUNS Jupiter Neurosciences, Inc.

NAS · US · Healthcare · Biotechnology · jupiterneurosciences.com
2.770USD-2.46%Mkt Cap: 3.65M $P/E: —

Jupiter Neurosciences, Inc., a clinical stage research and development pharmaceutical company, engages in the development of therapeutics for central nervous system disorders and rare diseases in the United States and in…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$127.47BUSDP/E 29.3
MRNA
Moderna, Inc.
$78.65BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.14BUSDP/E 18.3
ARGX
argenx SE
$51.48BUSDP/E 31.2
ARGX
argenx SE
$48.23BUSDP/E 31.4
UCB
UCB SA
$41.82BUSDP/E 17.8
RVMD
Revolution Medicines, Inc.
$40.32BUSD
ONC
BeOne Medicines AG
$39.83BUSDP/E 62.6
RPRX
Royalty Pharma plc
$32.48BUSDP/E 29.9
ALNY
Alnylam Pharmaceuticals, Inc.
$30.04BUSDP/E 37.9
ROIV
Roivant Sciences Ltd.
$24.71BUSD
BNTX
BioNTech SE
$23.13BUSD
INCY
Incyte Corporation
$22.85BUSDP/E 14.4
GMAB
Genmab A/S
$22.17BUSDP/E 28.4
INSM
Insmed Incorporated
$21.94BUSD
GMAB
Genmab A/S
$21.10BUSDP/E 29.1
ASND
Ascendis Pharma A/S
$14.65BUSDP/E 17.1
EXEL
Exelixis, Inc.
$14.62BUSDP/E 18.6
JAZZ
Jazz Pharmaceuticals plc
$14.44BUSDP/E 15.2
SMMT
Summit Therapeutics Inc.
$13.70BUSD

Key Statistics

Company
Market Cap3.65M USD
Enterprise Value2.43M USD
Revenue (TTM)64.69K USD
Gross Profit17.57K USD
Net Income (TTM)-8.64M USD
Revenue/Share0.13 USD
Last Price2.770 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees5
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)47.67
PEG—
EV/EBITDA—
EV/Revenue37.56
P/S58.29
P/B-5.19
EPS (TTM)-22.34
EPS (Forward)0.06
52W Range
2.2510% of range135.75
52W High135.75 USD
52W Low2.251 USD
Profitability
Gross Margin80.59%
Oper. Margin-11313.45%
EBITDA Margin0.00%
Profit Margin-39662.77%
ROE471.92%
ROA-155.37%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-5.41M USD
CapEx (TTM)—
FCF Margin-5041.33%
FCF Yield-89.30%
Net Debt227.20K USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity-2.90
Current Ratio0.66
Quick Ratio0.40
Book Value/Sh-0.55 USD
Cash/Share1.98 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:75
Split DateAug 7, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.1.32M
Float564.08K
Insiders29.96%
Institutions2.25%
Short Interest
Short Ratio0.0d
Short % Float4.62%
Short % Out.3.98%
Shares Short52.49K
Short (prev mo.)29.68K
Technical
SMA 504.423 (-37.4%)
SMA 20027.79 (-90.0%)
Beta—
S&P 52W Chg16.45%
Avg Vol (30d)87.68K
Avg Vol (10d)71.31K
Technical Indicators
RSI (14)38.6
MACD-0.5187
MACD Signal-0.6904
MACD Hist.+0.1716
BB Upper3.308 USD
BB Middle2.806 USD
BB Lower2.304 USD
BB Width35.80%
ATR (14)0.4348 USD
Vol Ratio (20d)0.40x